Skip to main content
Clinical Trials/NCT00356330
NCT00356330
Unknown
N/A

Study to Evaluate Safety of Cardiac Pacemakers in MR Imaging at 3T Tesla

University Hospital, Bonn1 site in 1 country75 target enrollmentJuly 26, 2006
ConditionsHeart Diseases

Overview

Phase
N/A
Intervention
Not specified
Conditions
Heart Diseases
Sponsor
University Hospital, Bonn
Enrollment
75
Locations
1
Last Updated
19 years ago

Overview

Brief Summary

To evaluate short-term and long-term effects by MR imaging at 3T on the technical and functional status of cardiac pacemakers.

Detailed Description

Recently, a shift could be observed from cardiac pacemakers being an absolute contraindication to being a relative contraindication for MR imaging at 1.5 Tesla, depending on a patient-per-patient risk-benefit-evaluation, which includes an urgent clinical need for MR imaging (other imaging modalities non-conclusive) and co-morbidities (especially cardiac co-morbidities). At the same time, MR imaging at 3 Tesla is evolving from a research application only to an important imaging modality today. Using the improved signal-to-noise-ratio, high field MR-Systems with a field strength of 3 Tesla offer a variety of diagnostic advantages to 1.5 Tesla systems. These advantages lead to a higher sensitivity and specificity in diagnosing, foremost neurological, disorders. In this study, we evaluate the safety of MR imaging of the brain in patients with cardiac pacemakers at 3T.

Registry
clinicaltrials.gov
Start Date
July 26, 2006
End Date
TBD
Last Updated
19 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Bonn

Eligibility Criteria

Inclusion Criteria

  • Urgent need for an MRI examination
  • Stable pacemaker physical parameters
  • Battery voltage \> 2.7 V
  • Battery impedance \< 2000 Ohm
  • Battery estimated remaining lifetime \> 6 months
  • Lead impedances 200-2000 Ohm
  • Stable pacing parameters
  • Pacing capture threshold \<2.5V at a pulse duration of 0.4ms
  • Sensing \> 5mV
  • Minimum 3 months since pacemaker and lead implantation

Exclusion Criteria

  • History of ventricular tachycardia (VT) or ventricular fibrillation
  • Unstable angina
  • Myocardial infarction within the previous 3 months
  • Cardiothoracic surgery within the previous 3 months
  • Presence of an abdominal pacemaker with lead length \> 70 cm
  • Presence of MRI incompatible bioimplants or other MRI incompatible materials

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials